norrin



norrin

K1KK1T2TT2D3DD3S4SS4S5SS5F6FF6L7LL7M8MM8D9DD9S10SS10Q11QQ11R12RR12C13CC13M14MM14R15RR15H16HH16H17HH17Y18YY18V19VV19D20DD20S21SS21I22II22S23SS23H24HH24P25PP25L26LL26Y27YY27K28KK28C29CC29S30SS30S31SS31K32KK32M33MM33V34VV34L35LL35L36LL36A37AA37R38RR38C39CC39E40EE40G41GG41H42HH42C43CC43S44SS44Q45QQ45A46AA46S47SS47... and 60 more residue(s)...... and 60 more residue(s)

SMILES None
InChIKey None
Sequence KTDSSFLMDSQRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECSS

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

norrin

K1KK1T2TT2D3DD3S4SS4S5SS5F6FF6L7LL7M8MM8D9DD9S10SS10Q11QQ11R12RR12C13CC13M14MM14R15RR15H16HH16H17HH17Y18YY18V19VV19D20DD20S21SS21I22II22S23SS23H24HH24P25PP25L26LL26Y27YY27K28KK28C29CC29S30SS30S31SS31K32KK32M33MM33V34VV34L35LL35L36LL36A37AA37R38RR38C39CC39E40EE40G41GG41H42HH42C43CC43S44SS44Q45QQ45A46AA46S47SS47... and 60 more residue(s)...... and 60 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.